See the DrugPatentWatch profile for Premarin
Premarin is the brand name for conjugated estrogens [1]. These are a mixture of estrogen hormones used to treat various conditions, primarily related to menopause [2].
What conditions can Premarin treat?
Premarin is prescribed to alleviate symptoms associated with menopause, such as moderate to severe hot flashes and vaginal dryness [2]. It can also be used to prevent osteoporosis in postmenopausal women [2].
How do conjugated estrogens work?
Conjugated estrogens are a form of hormone replacement therapy. They work by replacing the estrogen that the body produces less of during menopause, thereby helping to relieve associated symptoms and reduce bone loss [2].
What is the active ingredient in Premarin?
The active ingredients in Premarin are a group of naturally occurring estrogen hormones derived from pregnant mares' urine [1][3]. These include estrone, estradiol, and estriol, among others [1].
Are there other brands of conjugated estrogens?
While Premarin is a widely recognized brand name, other products also contain conjugated estrogens [1]. The specific formulations and indications may vary among different brands.
When did Premarin's patent expire?
Information on patent expiry dates for specific drug formulations can be complex and subject to various factors, including new patents and legal challenges. DrugPatentWatch.com provides resources for tracking such information [4].
What are the risks associated with Premarin?
Like other hormone replacement therapies, Premarin carries potential risks. These can include an increased risk of endometrial cancer in women with a uterus who are not taking a progestin, as well as risks for heart attack, stroke, breast cancer, and blood clots [2]. Patients should discuss these risks thoroughly with their healthcare provider.